US EditionPublished • loading... • Updated
Novo’s Ozempic Enters Indian Market Ahead of Generic Flood
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Ozempic Launched in India: Weekly Injection Starts at ₹2,200 - discountwalas
A Danish pharma major announced the launch of a popular drug in India. And then the once-weekly injection, Ozempic, became available for Type 2 diabetes management. That happened on Friday. Novo Nordisk, the manufacturer, has officially launched Ozempic (injectable semaglutide) in the Indian market. This is a big deal for adults managing uncontrolled Type 2 diabetes mellitus (T2DM). Also Read | The S24 Ultra Steal: How to Get ₹35,000 Off During …
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
